Please provide your email address to receive an email when new articles are posted on . The most frequent cause of death in patients with rheumatoid arthritis-associated interstitial lung disease and ...

Lung transplantation is the only curative treatment for IPF, but most patients are ineligible, necessitating focus on slowing disease progression. Nintedanib is recommended for PPF, while pirfenidone ...

Please provide your email address to receive an email when new articles are posted on . In patients with idiopathic pulmonary fibrosis, antifibrotic treatment may reduce the risk for all-cause ...

AIM-30 scoring system predicts 30-day mortality risk in IPF patients post-acute exacerbation using eight clinical variables. The system categorizes patients into low, moderate, and high-risk groups, ...

Credit: Getty Images. Based on the 2016 International Working Group (IWG) diagnostic criteria for idiopathic pulmonary fibrosis (IPF), outcomes are relatively similar between patients with IPF with ...

Pooled data from three key studies confirms that OFEV® slows disease progression by approximately 50% as measured by decline in forced vital capacity (FVC)*1-8 The pooled analysis also demonstrated ...

Background: This study aims to elucidate the capability of periostin (POSTN) as a serum biomarker in diagnosing idiopathic pulmonary fibrosis (IPF), assessing disease severity, and predicting acute ...

Acute exacerbations (AEs) are both common in rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and are a frequent cause of imminent mortality, a retrospective Japanese study suggests.

CHAMPAIGN, Ill. -- A bacterial protein fragment instigates lung tissue death in pulmonary fibrosis, a mysterious disease affecting millions of people worldwide, according to a new study from ...

The FINANCIAL — Pooled analysis from the TOMORROW and INPULSIS trials, recently published in Respiratory Medicine, provides further evidence that OFEV (nintedanib) significantly reduces the risk of ...